Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results

Caroline Thomas1, Isabelle Durand-Zaleski2, Jérôme Frenkiel2

  • 1Service d'oncologie-hématologie et immunologie pédiatrique, CHU Nantes, Nantes, France.

Insights

Newborn screening for Severe Combined Immunodeficiency (SCID) using T-cell receptor excision circles (TRECs) is feasible and effective. This method aids in early diagnosis and treatment, potentially preventing infant mortality from SCID.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Severe Combined Immunodeficiency (SCID) comprises genetic disorders severely impairing cellular and humoral immunity.
  • Infants with SCID are vulnerable to fatal infections within months if untreated.
  • Quantification of T-cell receptor excision circles (TRECs) is a sensitive screening method for SCID.

Purpose of the Study:

  • To evaluate the feasibility, economic, and clinical utility of nationwide newborn screening for SCID in France.
  • To assess the effectiveness of TREC quantification for detecting severe T-cell lymphopenia.

Main Methods:

  • A nationwide newborn screening program for SCID was implemented, analyzing TRECs on Guthrie cards.
  • The study compared 190,517 screened infants with a control group of 1.4 million infants diagnosed without screening.
  • Data on lymphopenia, SCID diagnoses, and costs were collected and analyzed.

Main Results:

  • The screening identified 62 lymphopenic infants, including three with SCID.
  • The cost per newborn screening ranged from €4.7 to €8.15.
  • The average 18-month cost for screened infants was higher than for the control group, though the difference was not fully ascertainable.

Conclusions:

  • Routine newborn screening for SCID is demonstrated to be feasible and effective in a large-scale study.
  • SCID screening aids in diagnosing non-SCID lymphopenia and can prevent SCID-related deaths before treatment.
  • Economic evaluation provides cost-per-test data for implementing nationwide screening programs.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
334
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
491
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
332
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
542